|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1-Antitrypsin Polymerizes in the Lung and Acts as a Neutrophil Chemoattractant*
* From the Department of Medicine (Drs. Mulgrew, Taggart, Greene, ONeill, and McElvaney, and Mr. Lawless), Respiratory Research Division, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland; and the Pulmonary and Critical Care Medicine Division (Dr. Brantly), University of Florida School of Medicine, Gainesville, FL.
Correspondence to: Noel G. McElvaney, MD, Department of Medicine, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin 9, Ireland; e-mail: gmcelvaney{at}rcsi.ie
Background:
1-antitrypsin (A1AT) is an abundant protein that is synthesized in the liver and is secreted into the plasma. From the plasma, A1AT diffuses into various body compartments, including the lung where it provides much of the antiprotease protection. The current understanding of the pathogenesis of emphysema in A1AT-deficient individuals focuses on the polymerization of mutant protein within the liver, which results in a deficiency of circulating A1AT and a protease-antiprotease imbalance in the lungs.
Methods and results: In this study, we evaluated BAL fluid samples from five healthy volunteers, five individuals with ZA1AT deficiency, and an individual with the PiZZ phenotype who had received a liver transplant. We show that the lung itself is a source of A1AT. In addition, the Z protein formed in the lung polymerizes, and these polymers are detectable in lung epithelial lining fluid by enzyme-linked immunosorbent assay and Western blot analysis. Finally, we show that polymeric ZA1AT is a potent neutrophil chemoattractant that is similar to polymerized MA1AT.
Conclusions: Our findings suggest that the polymerization of locally produced ZA1AT is a contributory factor to the lung inflammation experienced by those with A1AT deficiency and that standard antiprotease therapies may not address this problem.
Key Words: chemoattractant polymerization Z
1-antitrypsin
This article has been cited by other articles:
![]() |
Y.-P. Chang, R. Mahadeva, W.-S. W. Chang, A. Shukla, T. R. Dafforn, and Y.-H. Chu Identification of a 4-mer Peptide Inhibitor that Effectively Blocks the Polymerization of Pathogenic Z {alpha}1-Antitrypsin Am. J. Respir. Cell Mol. Biol., November 1, 2006; 35(5): 540 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Senn, E. W. Russi, M. Imboden, and N. M. Probst-Hensch {alpha}1-Antitrypsin deficiency and lung disease: risk modification by occupational and environmental inhalants Eur. Respir. J., November 1, 2005; 26(5): 909 - 917. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Taggart, C. M. Greene, T. P. Carroll, S. J. O'Neill, and N. G. McElvaney Elastolytic Proteases: Inflammation Resolution and Dysregulation in Chronic Infective Lung Disease Am. J. Respir. Crit. Care Med., May 15, 2005; 171(10): 1070 - 1076. [Full Text] [PDF] |
||||
![]() |
R. Mahadeva, C. Atkinson, Z. Li, S. Stewart, S. Janciauskiene, D. G. Kelley, J. Parmar, R. Pitman, S. D. Shapiro, and D. A. Lomas Polymers of Z {alpha}1-Antitrypsin Co-Localize with Neutrophils in Emphysematous Alveoli and Are Chemotactic in Vivo Am. J. Pathol., February 1, 2005; 166(2): 377 - 386. [Abstract] [Full Text] [PDF] |
||||
Read all eLetters
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |